tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
INTS
Intensity Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see INTS full AI Analyst Report?

Intensity Therapeutics, Inc. (INTS) Stock News & Sentiment

252 Followers
INTS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INTS Upcoming Earnings Report: What to Expect?
6d ago
INTS
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
Premium
Company Announcements
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
2M ago
8K
INTS
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
Premium
Company Announcements
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
5M ago
INTS
Intensity Therapeutics Expands ATM Equity Offering Capacity
Premium
Company Announcements
Intensity Therapeutics Expands ATM Equity Offering Capacity
5M ago
8K
INTS
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
5M ago
INTS
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
Premium
Company Announcements
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
5M ago
8K
INTS
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
6M ago
SMX
WTO
More INTS News >

INTS News on the Web

Intensity Therapeutics price target lowered to $15 from $30 at Alliance Global
TipRanks News
Bearish
INTS Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
Cue Biopharma Appoints Ahlers As CFO Following IND Filing And Pipeline Progress
rttnews
Neutral
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
TipRanks News
Neutral
Intensity Therapeutics Wins 2026 Award for Cancer Treatment Innovation—What Does This Mean for Patients and Investors?
Market Chameleon
Neutral
Intensity Therapeutics, Inc. (INTS) Receives a Buy from Alliance Global Partners
TipRanks News
Neutral
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
TipRanks News
Bullish
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
INTS
Sector Average
Media Buzz
This Week3 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INTS’s Media Buzz Sentiment?
3 articles about INTS were published this week. In an average week, 0.5 articles are published.
    What is INTS’s weekly average amount of articles?
    In an average week, 0.5 articles about INTS are published.
      What is INTS’s News Sentiment?
      50% of articles about INTS were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        ABTAbbott Laboratories
        FENCFennec Pharmaceuticals
        ALLOAllogene Therapeutics
        ORKAOruka Therapeutics
        RCKTRocket Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week